CG:600079 Humanwell Healthcare (Group) Co.,Ltd

Humanwell Healthcare (Group) Co., Ltd. is principally engaged in pharmaceutical business. The Company mainly provides medicines and condoms. The Company's medicine products mainly include family planning medicines, anesthesia, Uyghur medicines, traditional Chinese medicines, medicines for central nervous system, bio-medicines and others. In addition, it is involved in the provision of medical equipment. On January 1, 2014, it announced that it transferred the real estate business, including 85% stake in a Wuhan-based property company and two real estate development projects, to its controlling shareholder.

20.57 CNY
As of 01/25/2022


Security Information
Category1:  Global Equity
Category2:  Common stocks
Category3:  Emerging markets
GICS sector:  Health Care
Industry:  Drug Manufacturers-Specialty &
Index country:  China
Country of incorporation:  China
IPO date:  01/03/2000
Stock exchange:    Shanghai Stock Exchange
Exchange country:   China
Market cap:   33,592,248,320 CNY
Current dividend yield:   0.46%
Sedol:      6000190

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy